findings from RDSafe and DonorKids QL studies Galen Switzer 1 , Jessica Bruce 1 , Bronwen Shaw 2 , Vidya Kuniyil 1 , James Varni 3 , Brandan Butler 4 , Connor Erickson 4 , Alisha Mussetter 4 , Allison Weiss 4 , Hisham Abdel-Azim 5 , Paibel Aguayo-Hiraldo 6 , Eric Anderson 7 , Victor Aquino 8 , Karlie Boone 9 , Joseph Chewning 10 , Ann Dahlberg 11 , Christopher Dvorak 12 , Jorge Galvez-Silva 13 , Ann Haight 14 , Jennifer Hoag 15 , Michelle Hudspeth 16 1 University of Pittsburgh, Pittsburgh, Pennsylvania, USA, 2 Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin, USA, 3 Colleges of Architecture and Medicine, Texas A&M University, College Station, Texas, USA, 4 CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota, USA, 5 Division of Transplant and Cell Therapy/Hematological Malignancies, Departments of Pediatrics, Loma Linda University, Loma Linda, USA, 6 Childrens Hospital Los Angeles, University of Southern California, Los Angeles, USA, 7 University of California/Rady Childrens Hospital, San Diego, USA, 8 UT Southwestern Medical Center Dallas, Dallas, USA, 9 Pediatric Hematology/Oncology, University of Colorado, Aurora, USA, 10 Pediatric Blood and Marrow Transplant Program, University of Alabama at Birmingham, Birmingham, USA, 11 Clinical Research Division, Fred Hutchinson Cancer Research Center, Dept of Pediatrics, University of Washington, Seattle, USA, 12 Division of Pediatric Allergy, Immunology & Bone Marrow Transplantation, University of California San Francisco, San Francisco, USA, 13 Blood and Bone Marrow Transplant Program, Nicklaus Childrens Hospital, Miami, USA, 14 Aflac Cancer and Blood Center, Emory University School of Medicine, Atlanta, USA, 15 Department of Pediatrics, Medical College of Wisconsin, Milwaukee, USA, 16 Pediatric Hematology/Oncology, Medical University of South Carolina, Charleston, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :207.2 Aims Although the use of minors as HSC donors is medically and legally accepted there is a lack of understanding of HRQoL effects of pediatric HSC donation
Its not illegal, but phentermine has its drawbacks
Standard Criteria for Donation: Age: Donors must generally be between the ages of 18 and 74
Can potentially reduce the efficacy of oral contraceptives, requiring additional contraceptive measures
